Backlight module maker Darwin held its shareholders’ meeting on June 17, 2026, and said it remains cautiously optimistic about 2026 revenue as its new businesses continue to gain traction. The company cited fresh commercial display orders in the US market and said organ-chip partner Anivance AI is also listed on an “Nvidia backdrop,” adding momentum to its medical technology push.